BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24811164)

  • 1. RNA interference screening to detect targetable molecules in hematopoietic stem cells.
    Karlsson C; Rak J; Larsson J
    Curr Opin Hematol; 2014 Jul; 21(4):283-8. PubMed ID: 24811164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forward RNAi Screens in Human Hematopoietic Stem Cells.
    Galeev R; Karlsson C; Baudet A; Larsson J
    Methods Mol Biol; 2017; 1622():29-50. PubMed ID: 28674799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forward RNAi screens in human stem cells.
    Karlsson C; Larsson J; Baudet A
    Methods Mol Biol; 2010; 650():29-43. PubMed ID: 20686941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous knockdown of p18INK4C, p27Kip1 and MAD1 via RNA interference results in the expansion of long-term culture-initiating cells of murine bone marrow cells in vitro.
    Wang YY; Yang Y; Chen Q; Yu J; Hou Y; Han L; He J; Jiao D; Yu H
    Acta Biochim Biophys Sin (Shanghai); 2008 Aug; 40(8):711-20. PubMed ID: 18685787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput RNAi screening for the identification of novel targets.
    Henderson MC; Azorsa DO
    Methods Mol Biol; 2013; 986():89-95. PubMed ID: 23436407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forward RNAi screens in primary human hematopoietic stem/progenitor cells.
    Ali N; Karlsson C; Aspling M; Hu G; Hacohen N; Scadden DT; Larsson J
    Blood; 2009 Apr; 113(16):3690-5. PubMed ID: 19188664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of gene expression by siRNA in hematopoietic cells.
    Scherr M; Eder M
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):262-9. PubMed ID: 15782549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi screen identifies MAPK14 as a druggable suppressor of human hematopoietic stem cell expansion.
    Baudet A; Karlsson C; Safaee Talkhoncheh M; Galeev R; Magnusson M; Larsson J
    Blood; 2012 Jun; 119(26):6255-8. PubMed ID: 22555972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput RNAi screening to dissect cellular pathways: a how-to guide.
    Falschlehner C; Steinbrink S; Erdmann G; Boutros M
    Biotechnol J; 2010 Apr; 5(4):368-76. PubMed ID: 20349460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncology studies using siRNA libraries: the dawn of RNAi-based genomics.
    Sachse C; Echeverri CJ
    Oncogene; 2004 Nov; 23(51):8384-91. PubMed ID: 15517020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From sequence to function: using RNAi to elucidate mechanisms of human disease.
    Wolters NM; MacKeigan JP
    Cell Death Differ; 2008 May; 15(5):809-19. PubMed ID: 18202701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent.
    Mishima S; Nagai A; Abdullah S; Matsuda C; Taketani T; Kumakura S; Shibata H; Ishikura H; Kim SU; Masuda J
    Eur J Haematol; 2010 Jun; 84(6):538-46. PubMed ID: 20088916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian RNAi: a practical guide.
    Sandy P; Ventura A; Jacks T
    Biotechniques; 2005 Aug; 39(2):215-24. PubMed ID: 16116795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-scale loss-of-function screening with a lentiviral RNAi library.
    Root DE; Hacohen N; Hahn WC; Lander ES; Sabatini DM
    Nat Methods; 2006 Sep; 3(9):715-9. PubMed ID: 16929317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of RNAi library to oncology investigation].
    Weng DH; Wang SX; Ma D
    Ai Zheng; 2008 Nov; 27(11):1229-32. PubMed ID: 19000460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
    ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
    Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vector-based RNAi approaches for stable, inducible and genome-wide screens.
    Fewell GD; Schmitt K
    Drug Discov Today; 2006 Nov; 11(21-22):975-82. PubMed ID: 17055406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative RNAi Screens in Isogenic Human Stem Cells Reveal SMARCA4 as a Differential Regulator.
    Güneş C; Paszkowski-Rogacz M; Rahmig S; Khattak S; Camgöz A; Wermke M; Dahl A; Bornhäuser M; Waskow C; Buchholz F
    Stem Cell Reports; 2019 May; 12(5):1084-1098. PubMed ID: 31031192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible gene and shRNA expression in resident hematopoietic stem cells in vivo.
    Laurenti E; Barde I; Verp S; Offner S; Wilson A; Quenneville S; Wiznerowicz M; Macdonald HR; Trono D; Trumpp A
    Stem Cells; 2010 Aug; 28(8):1390-8. PubMed ID: 20641037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.
    Hosen N; Shirakata T; Nishida S; Yanagihara M; Tsuboi A; Kawakami M; Oji Y; Oka Y; Okabe M; Tan B; Sugiyama H; Weissman IL
    Leukemia; 2007 Aug; 21(8):1783-91. PubMed ID: 17525726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.